Meloprol

Meloxicam, the active ingredient in Meloprol, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain in adults and is commonly prescribed by rheumatologists and primary care physicians.

GNH USA supplies Meloprol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Meloxicam is an NSAID used to manage inflammatory joint disorders and acute pain.

- Osteoarthritis: reduces joint pain and improves functional ability. - Rheumatoid arthritis: decreases synovial inflammation and slows joint damage progression. - Ankylosing spondylitis: alleviates spinal pain and stiffness. - Acute pain: provides short‑term relief of moderate to severe musculoskeletal pain.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Stomach pain or dyspepsia. - Nausea. - Headache.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular thrombotic events (e.g., myocardial infarction, stroke). - Severe skin reactions such as Stevens‑Johnson syndrome.

Before initiating therapy, consider the following precautions.

- Renal function: assess baseline kidney function and monitor periodically. - Blood pressure: monitor for hypertension, especially in patients with cardiovascular risk. - Hypersensitivity: avoid in individuals with known allergy to meloxicam or other NSAIDs. - Elderly patients: use the lowest effective dose and monitor for adverse events. - Concomitant anticoagulants: evaluate bleeding risk. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Meloxicam can interact with several medicines; clinical judgment is required.

Major Interactions (Avoid): - Warfarin or other anticoagulants: increased bleeding risk. - Concurrent NSAIDs or aspirin: heightened gastrointestinal toxicity. - ACE inhibitors or ARBs: potential for reduced renal function.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate renal impairment. - Methotrexate: possible increase in methotrexate toxicity.